Cambodia vs Euro area: Access to anti-retroviral drugs, male
Cambodia
96.0%
in 2024
Euro area
87.0%
in 2022
Cambodia rank
3rd
Euro area rank
1st
Access to anti-retroviral drugs, male over time
- Cambodia
- Euro area
How they compare
Cambodia currently reports 96.0% against 87.0% in Euro area, a difference of 9.0%.
That makes Cambodia's figure about 1.1 times Euro area's.
Across all 23 years both countries report, Euro area has been ahead every year.
Cambodia ranks 3rd and Euro area ranks 1st of 141 countries.
Euro area has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Euro area | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.4% | 50.7% | 34.3% | Euro area |
| 2010s | 62.4% | 75.2% | 12.8% | Euro area |
| 2020s | 82.0% | 86.1% | 4.1% | Euro area |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cambodia or Euro area?
- Cambodia, at 96.0% against 87.0% in Euro area as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cambodia and Euro area?
- 9.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Euro area?
- 23 years are reported by both, from 2000 to 2022.
- How do Cambodia and Euro area rank globally for access to anti-retroviral drugs, male?
- Cambodia ranks 3rd and Euro area ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.